Boston Scientific (BSX) Income from Continuing Operations (2009 - 2026)

Boston Scientific has disclosed Income from Continuing Operations across 18 years of filings, most recently posting 1338000000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 1338000000.0, up 99.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 3559000000.0 (up 75.75% YoY), and the FY2025 annual result was 2892000000.0, up 56.66% from the prior year.
• Income from Continuing Operations came in at 1338000000.0 for Q1 2026 at Boston Scientific, up from 670000000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 1338000000.0 in Q1 2026 to a low of 111000000.0 in Q1 2022.
• The 5-year median for Income from Continuing Operations is 493000000.0 (2024), against an average of 492294117.65.
• Across the five-year window, Income from Continuing Operations tumbled 67.45% in 2022 and surged 257.45% in 2023, its largest moves.
• Boston Scientific's Income from Continuing Operations stood at 141000000.0 in 2022, then soared by 257.45% to 504000000.0 in 2023, then advanced by 11.51% to 562000000.0 in 2024, then grew by 19.22% to 670000000.0 in 2025, then surged by 99.7% to 1338000000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 1338000000.0 (Q1 2026), 670000000.0 (Q4 2025), and 756000000.0 (Q3 2025), per Business Quant data.